| P2093 | author name string | A Hollinshead | |
| P2860 | cites work | Oral administration of BCG as a local immunotherapy of gastrointestinal cancer | Q71399711 |
| | Lung tumor-associated antigens: thin layer immunoassay | Q71821612 |
| | Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions | Q72741408 |
| | Immunotherapy of renal cell carcinoma | Q72744153 |
| | Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial | Q93570169 |
| | Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases | Q28366387 |
| | Adjuvant BCG immunotherapy for malignant melanoma | Q34699843 |
| | Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung. | Q36999437 |
| | Immunology of metastasis. Can the immune response cope with disseminated tumor? | Q40116730 |
| | Suppressor T cells and the immune response to tumors | Q40116940 |
| | Transfusion Therapy with Platelets and Leukocytes | Q40154300 |
| | Clinical immunotherapy trials of bacterial components derived from Mycobacteria and Nocardia | Q40163887 |
| | Tuftsin, A Natural Activator of Phagocyte Cells: An Overviewa | Q40174207 |
| | Possible role of natural killer cells and other effector cells in immune surveillance against cancer | Q40180458 |
| | Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia. | Q40823649 |
| | Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia. | Q40832037 |
| | Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up | Q41427142 |
| | Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer. | Q41442571 |
| | Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group study | Q52707393 |
| | Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen | Q63446427 |
| | Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma. Analysis at the eighth year | Q69917094 |
| | Pilot trial of murine monoclonal antibodies in patients with advanced melanoma | Q70062026 |
| | Effect of adjuvant immunotherapy with Nocardia rubra cell-wall skeleton in lung cancer | Q70209473 |
| | Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM | Q70226896 |
| | Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial | Q70249808 |
| | Evaluation of postoperative immunotherapy of gastric cancer | Q70273777 |
| | Adjuvant immunotherapy with nonviablemycobacterium smegmatis in resected primary lung carcinoma a randomized clinical trial of 219 patients | Q70313330 |
| | Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation | Q70324925 |
| | Comparison of the efficacy of intravesical Bacillus Calmette-Guérin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer | Q70459589 |
| | [Clinical trials of plasma exchange therapy in patients with recurrent colon cancer] | Q70496596 |
| | Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma | Q70995286 |
| | Response of tumors to biologic modifiers and chemotherapeutic agents | Q71156893 |
| | Production of large quantities of human immunoglobulin in the ascites of athymic mice: implications for the development of anti-human idiotype monoclonal antibodies | Q71276660 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 85-103 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | Seminars in Immunopathology | Q15724576 |
| P1476 | title | Immunotherapy trials: current status and future directions with special emphasis on biologic drugs | |
| P478 | volume | 9 | |